152 related articles for article (PubMed ID: 22829208)
1. Vital staining with iodine solution in oral cancer: iodine infiltration, cell proliferation, and glucose transporter 1.
Xiao T; Kurita H; Shimane T; Nakanishi Y; Koike T
Int J Clin Oncol; 2013 Oct; 18(5):792-800. PubMed ID: 22829208
[TBL] [Abstract][Full Text] [Related]
2. Difference in glycogen metabolism (glycogen synthesis and glycolysis) between normal and dysplastic/malignant oral epithelium.
Aizawa H; Yamada SI; Xiao T; Shimane T; Hayashi K; Qi F; Tanaka H; Kurita H
Arch Oral Biol; 2017 Nov; 83():340-347. PubMed ID: 28892665
[TBL] [Abstract][Full Text] [Related]
3. Iodine penetration and glycogen distribution in vital staining of oral mucosa with iodine solution.
Xiao T; Kurita H; Li X; Qi F; Shimane T; Aizawa H; Uehara S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):754-9. PubMed ID: 24726416
[TBL] [Abstract][Full Text] [Related]
4. Cell proliferation and tumour suppressor gene expression in iodine unstained area surrounding oral squamous cell carcinoma.
Yokoo K; Noma H; Inoue T; Hashimoto S; Shimono M
Int J Oral Maxillofac Surg; 2004 Jan; 33(1):75-83. PubMed ID: 14690663
[TBL] [Abstract][Full Text] [Related]
5. Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.
Ohta K; Ogawa I; Ono S; Taki M; Mizuta K; Miyauchi M; Takechi M; Shigeishi H; Takata T; Kamata N
Oncol Rep; 2010 Jul; 24(1):9-14. PubMed ID: 20514438
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance of carbonic anhydrase 9, glucose transporter-1, Ki-67 and p53 expression in oral squamous cell carcinoma.
Kondo Y; Yoshikawa K; Omura Y; Shinohara A; Kazaoka Y; Sano J; Mizuno Y; Yokoi T; Yamada S
Oncol Rep; 2011 May; 25(5):1227-33. PubMed ID: 21399882
[TBL] [Abstract][Full Text] [Related]
7. Vital staining with iodine solution in delineating the border of oral dysplastic lesions.
Kurita H; Kurashina K
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Mar; 81(3):275-80. PubMed ID: 8653460
[TBL] [Abstract][Full Text] [Related]
8. Expression of glucose transporter protein-1 (Glut-1) in ocular surface squamous neoplasia.
Gurses I; Doganay S; Mizrak B
Cornea; 2007 Aug; 26(7):826-30. PubMed ID: 17667617
[TBL] [Abstract][Full Text] [Related]
9. Quantification of telomerase activity of regions unstained with iodine solution that surround oral squamous cell carcinoma.
Yajima Y; Noma H; Furuya Y; Nomura T; Yamauchi T; Kasahara K; Hatada K; Takano M
Oral Oncol; 2004 Mar; 40(3):314-20. PubMed ID: 14747063
[TBL] [Abstract][Full Text] [Related]
10. Content and distribution of glycogen in oral epithelial dysplasia.
Isacsson G; Shear M
Scand J Dent Res; 1981 Feb; 89(1):79-88. PubMed ID: 6165065
[TBL] [Abstract][Full Text] [Related]
11. p53 expression in oral cancer: observations of a South Indian study.
Pillay M; Vasudevan DM; Rao CP; Vidya M
J Exp Clin Cancer Res; 2003 Sep; 22(3):447-51. PubMed ID: 14582705
[TBL] [Abstract][Full Text] [Related]
12. Alterations in glucose metabolism proteins responsible for the Warburg effect in esophageal squamous cell carcinoma.
de Andrade Barreto E; de Souza Santos PT; Bergmann A; de Oliveira IM; Wernersbach Pinto L; Blanco T; Rossini A; Pinto Kruel CD; Mattos Albano R; Ribeiro Pinto LF
Exp Mol Pathol; 2016 Aug; 101(1):66-73. PubMed ID: 27260309
[TBL] [Abstract][Full Text] [Related]
13. Histopathogenesis of non-HPV-related differentiated oral squamous intraepithelial neoplasia.
Purgina B; Hassan M; Olberg B; Lai CK; Mai KT
Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):273-9. PubMed ID: 25356942
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 Prognostic Value in Different Histological Grades of Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Takkem A; Barakat C; Zakaraia S; Zaid K; Najmeh J; Ayoub M; Seirawan MY
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3279-3286. PubMed ID: 30486632
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
[TBL] [Abstract][Full Text] [Related]
16. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of p53 and Ki67 and lack of EBV expression in oral squamous cell carcinoma.
Iamaroon A; Khemaleelakul U; Pongsiriwet S; Pintong J
J Oral Pathol Med; 2004 Jan; 33(1):30-6. PubMed ID: 14675138
[TBL] [Abstract][Full Text] [Related]
18. Risk prediction for malignant conversion of oral epithelial dysplasia by hypoxia related protein expression.
Zhang X; Han S; Han HY; Ryu MH; Kim KY; Choi EJ; Cha IH; Kim J
Pathology; 2013 Aug; 45(5):478-83. PubMed ID: 23811806
[TBL] [Abstract][Full Text] [Related]
19. Asymmetrical proliferative pattern loss during malignant transformation of the oral mucosa.
González-Moles MA; Plaza-Campillo J; Ruiz-Ávila I; Herrera P; Bravo M; Gil-Montoya JA
J Oral Pathol Med; 2014 Aug; 43(7):507-13. PubMed ID: 25184162
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of immunohistochemical expression of MCM2 and Ki67 in oral epithelial dysplasia and oral squamous cell carcinoma.
Swain S; Nishat R; Ramachandran S; Raghuvanshi M; Behura SS; Kumar H
J Cancer Res Ther; 2022; 18(4):997-1002. PubMed ID: 36149152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
